A bill to require the Food and Drug Administration to expedite review of pharmaceuticals that are approved for marketing in the European Union; to the Committee on Energy and Commerce.

H.R. 4918 — A bill to require the Food and Drug Administration to expedite review of pharmaceuticals that are approved for marketing in the European Union; to the Committee on Energy and Commerce.

By Mr. STIVERS (for himself and Mr. Ryan of Ohio), H5557 [19JN]